The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Isopropyl N-[2-({4-[N-(3-bromo-4-fluorophenyl)-N'-hydroxycarbamimidoyl]-1,2,5-oxadiazol-3-yl}amino)ethyl]-P-methylphosphonamidate ID: ALA4514159
PubChem CID: 155539196
Max Phase: Preclinical
Molecular Formula: C15H21BrFN6O4P
Molecular Weight: 479.25
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)OP(C)(=O)NCCNc1nonc1/C(=N/O)Nc1ccc(F)c(Br)c1
Standard InChI: InChI=1S/C15H21BrFN6O4P/c1-9(2)26-28(3,25)19-7-6-18-14-13(22-27-23-14)15(21-24)20-10-4-5-12(17)11(16)8-10/h4-5,8-9,24H,6-7H2,1-3H3,(H,18,23)(H,19,25)(H,20,21)
Standard InChI Key: GWFJYPOGGNSNNJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 29 0 0 0 0 0 0 0 0999 V2000
33.8309 -30.4176 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.4939 -29.9397 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.2395 -29.1589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4223 -29.1589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1679 -29.9397 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.9452 -28.7461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9407 -27.9290 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.6552 -29.1508 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.3606 -28.7382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6461 -27.5164 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.0700 -29.1454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7750 -28.7335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7708 -27.9155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0559 -27.5110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3539 -27.9252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4847 -29.1385 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
38.4757 -27.5020 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
32.7124 -28.7503 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.0052 -29.1598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2970 -28.7521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5898 -29.1616 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.8816 -28.7539 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
29.1744 -29.1634 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.8770 -27.9331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8770 -29.5675 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.4662 -28.7558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7590 -29.1653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4651 -27.9386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4 5 2 0
2 3 2 0
1 2 1 0
3 4 1 0
5 1 1 0
3 6 1 0
6 7 2 0
6 8 1 0
8 9 1 0
7 10 1 0
9 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 9 1 0
12 16 1 0
13 17 1 0
4 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
22 24 1 0
22 25 2 0
23 26 1 0
26 27 1 0
26 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 479.25Molecular Weight (Monoisotopic): 478.0529AlogP: 3.47#Rotatable Bonds: 9Polar Surface Area: 133.90Molecular Species: ACIDHBA: 8HBD: 4#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 5.81CX Basic pKa: ┄CX LogP: 2.09CX LogD: 0.57Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.11Np Likeness Score: -1.48
References 1. Du Q, Feng X, Wang Y, Xu X, Zhang Y, Qu X, Li Z, Bian J.. (2019) Discovery of phosphonamidate IDO1 inhibitors for the treatment of non-small cell lung cancer., 182 [PMID:31445231 ] [10.1016/j.ejmech.2019.111629 ]